Making the Case for All-Oral, Shorter Regimens for Children with Drug-Resistant Tuberculosis

Am J Respir Crit Care Med. 2023 Jul 15;208(2):130-131. doi: 10.1164/rccm.202304-0670VP.
No abstract available

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Child
  • Clinical Protocols
  • Humans
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents